NCT01131702View on ClinicalTrials.gov

Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 28, 2003

Study Completion Date

March 31, 2003

Conditions
Healthy
Interventions
DRUG

Ranitidine

Ranitidine Tablets, 300 mg

Trial Locations (1)

G1V 2K8

Anapharm Inc., Montreal

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY